company
as of 2026-07-01National Institute on Drug Abuse (NIDA)
at a glance
58 trials sponsored · 60 assets in the graph
Synthesized from structured facts only — each point cited above.
Financials
SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).
Pipeline
60 assets
ClozapineMinocyclineSarcosine0 mg/day bupropion-sr21 mg transdermal nicotine300 mg/day bupropion-sr42 mg transdermal nicotine replacementActive TMS stimulationActive deep transcranial magnetic stimulation (dTMS)Acute (24-hour) abstinenceAd libitum smoking/vapingBehavioral Treatment for Substance Abuse in SPMI (BTSAS)Behavioral counselingBrief adviceBupropionBupropion HClCET/PTCRAFT-EPCRAFT-FTCannabisCognitive Behavioral Group TherapyCognitive Remediation (CR)Contingency managementCounselor delivered telehealth interventionCritical Time Intervention (CTI)Delta-9-THC Medium DoseDelta-9-THC Very Low DoseDronabinolGabapentinMarijuanaNeutral CuesNicotine LozengesNicotine gumNicotine patchNicotine replacement therapyNicotine transdermal patchOxytocinPersistence Targeted Smoking Cessation in SMI (PTSC-S)PhysostigminePsychoeducationQuit on the Go App (formerly "Learn to Quit " App)RimonabantSmartphone coachingSmoking CuesSugar PillSupportive Treatment in Addiction Recovery (STAR)TAUTHCTransdermal nicotine patchVareniclineVery low nicotine content cigarettes[11-C]OMAR[11C]APP311active F8-coil delivered rTMSactive H-coil delivered rTMSbupropion SRcounselingdelta 9 tetrahydrocannabinolmotivational interviewingnicotine nasal spray
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
Clozapine
drugsmall molecule
Minocycline
drugsmall molecule
Sarcosine
drugDIETARY_SUPPLEMENT
0 mg/day bupropion-sr
drugsmall molecule
21 mg transdermal nicotine
drugsmall molecule
300 mg/day bupropion-sr
drugsmall molecule
42 mg transdermal nicotine replacement
drugsmall molecule
Active TMS stimulation
drugDEVICE